Free Review Articles on Colon and rectum (Neoplasia)                                 Metatextbook

Freie Reviews über Kolon und Rektum (Neubildung)                                 Look here for Journal Homepages

  • Colon and rectum (Neoplasia)
  • Capecitabine
  • Irinotecan
  • Oxaliplatin
  • Raltitrexed
  • Cetuximab
  • Bevacizumab
  • Panitumomab
  • Neoplasia (Inherited)
  • UFT
  • Lynch syndrome
  • Neoplasia (Carcinogenesis)
  • Genetic instability
  • Neoplasia (Tumor markers)
  • Mammary gland (Neoplasia)
  • KRAS
  • Ursodeoxycholic acid
  • Chemoprevention
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    11988Dukes' classification of rectal cancer.



    		+-nlSouth Med J 81(3):407-8 (1988)
    22003Colorectal polyps.



    		+-nlClin Med Res 1(3):261-2 (2003)
    32005Hereditary non-polyposis colon cancer.



    		+-nlUlster Med J 74(1):14-21 (2005)
    41992Familial adenomatous polyposis.



    		+-nlJ R Soc Med 85(2):63-5 (1992)
    52010The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes.



    		+-nlDtsch Arztebl Int 107(10):163-73 (2010)
    62009Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases.



    		+-nlDtsch Arztebl Int 106(51-52):843-8 (2009)
    72007A review of the role of capecitabine in the treatment of colorectal cancer.



    		+-nlTher Clin Risk Manag 3(3):421-31 (2007)
    82008The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.



    		+-nlHealth Technol Assess 12(15):iii-ix, xi-162 (2008)
    92007Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.



    		+-nlHealth Technol Assess 11(12):1-128, iii-iv (2007)
    102006Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.



    		+-nlHealth Technol Assess 10(45):1-141, iii-iv (2006)
    112006The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.



    		+-nlHealth Technol Assess 10(41):iii-iv, xi-xiv, 1-185 (2006)
    122010Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer.



    		+-nlCore Evid 5(-):61-76 (2010)
    132008Extracolonic manifestations of hereditary colorectal cancer syndromes.



    		+-nlClin Colon Rectal Surg 21(4):263-72 (2008)
    142009Early detection of and screening for colorectal neoplasia.



    		+-nlGut Liver 3(2):69-80 (2009)
    152008Noninvasive molecular biomarkers for the detection of colorectal cancer.



    		+-nlBMB Rep 41(10):685-92 (2008)
    162006Induction chemoradiation for rectal cancer.



    		+-nlArch Surg 141(12):1246-52; discussion 1253 (2006)
    171999Colorectal cancer in adolescents.



    		+-nlAnn R Coll Surg Engl 81(2):100-4 (1999)
    181995Colorectal cancer: surgical prophylaxis and chemoprevention.



    		+-nlAnn R Coll Surg Engl 77(5):372-6 (1995)
    191995Adjuvant chemotherapy for colorectal cancer.



    		+-nlAnn R Coll Surg Engl 77(2):81-4 (1995)
    202004Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.



    		+-nlAnn Surg 240(2):260-8 (2004)
    212002Long-term results of local excision for rectal cancer.



    		+-nlAnn Surg 236(4):522-29; discussion 529-30 (2002)
    222001Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience.



    		+-nlAnn Surg 233(6):778-85 (2001)
    232001Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer.



    		+-nlAnn Surg 233(2):157-8 (2001) McLeod RS
    241998Periampullary adenocarcinoma: analysis of 5-year survivors.



    		+-nlAnn Surg 227(6):821-31 (1998)
    251998Surgical treatment of adenocarcinoma of the rectum.



    		+-nlAnn Surg 227(6):800-11 (1998)
    261995Clinical behavior and prognostic factors of periampullary adenocarcinoma.



    		+-nlAnn Surg 222(5):632-7 (1995)
    271989Sphincter-saving procedures for distal carcinoma of the rectum.



    		+-nlAnn Surg 209(1):1-18 (1989)
    281988Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?



    		+-nlAnn Surg 207(6):670-8 (1988)
    291966Carcinoma of the distal large bowel: 32-year review of 1,026 cases.



    		+-nlAnn Surg 163(6):838-49 (1966)
    301966Cancer of the colon, rectum and anus: review of 1,687 cases.



    		+-nlAnn Surg 163(6):829-37 (1966)
    312004The evolution to stool DNA testing for colorectal cancer.



    		+-nlAliment Pharmacol Ther 19(12):1225-33 (2004)
    322003Review article: colorectal cancer chemotherapy.



    		+-nlAliment Pharmacol Ther 18(7):683-92 (2003)
    332002Review article: genetic testing and counselling for hereditary colorectal cancer.



    		+-nlAliment Pharmacol Ther 16(11):1843-57 (2002)
    342001Review article: non-systemic chemotherapy in the treatment of colorectal cancer-portal vein, hepatic arterial and intraperitoneal approaches.



    		+-nlAliment Pharmacol Ther 15(10):1527-41 (2001)
    352008Review article: panitumumab--a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer.



    		+-nlAliment Pharmacol Ther 28(3):269-81 (2008)
    362008Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.



    		+-nlAliment Pharmacol Ther 27(11):997-1005 (2008)
    372007Predictive and prognostic markers in colorectal cancer.



    		+-nlGastrointest Cancer Res 1(6):237-46 (2007)
    382010Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.



    		+-nlTarget Oncol 5(1):19-28 (2010)
    392009Implications of KRAS mutation status for the treatment of metastatic colorectal cancer.



    		+-nlTarget Oncol 4(4):311-22 (2009)
    402009Microsatellite instability: a predictive marker in metastatic colorectal cancer?



    		+-nlTarget Oncol 4(1):57-62 (2009)
    412008UFT (tegafur-uracil) in rectal cancer.



    		+-nlAnn Oncol 19(8):1371-8 (2008)
    422008Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 19 Suppl 2(-):ii33-4 (2008)
    432008Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 19 Suppl 2(-):ii31-2 (2008)
    442008Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up.



    		+-nlAnn Oncol 19 Suppl 2(-):ii29-30 (2008)
    452007Integrative decisions in rectal cancer.



    		+-nlAnn Oncol 18 Suppl 9(-):ix127-31 (2007)
    462007The multidisciplinary treatment of rectal cancer: pathology.



    		+-nlAnn Oncol 18 Suppl 9(-):ix122-6 (2007)
    472007Multidisciplinary treatment of rectal cancer: medical oncology.



    		+-nlAnn Oncol 18 Suppl 9(-):ix114-21 (2007)
    482007Radiotherapy for localized rectal cancer.



    		+-nlAnn Oncol 18 Suppl 9(-):ix105-13 (2007)
    492007Cetuximab: clinical results in colorectal cancer.



    		+-nlAnn Oncol 18 Suppl 6(-):vi8-10 (2007)
    502006A multimodality approach to localized rectal cancer.



    		+-nlAnn Oncol 17 Suppl 10(-):x129-34 (2006)
    512006The integration of targeted agents into systemic therapy of metastatic colorectal cancer.



    		+-nlAnn Oncol 17 Suppl 10(-):x122-8 (2006)
    522006Adjuvant therapy in colon cancer--what, when and how?



    		+-nlAnn Oncol 17(9):1347-59 (2006)
    532006Alternative clinical end points in rectal cancer--are we getting closer?



    		+-nlAnn Oncol 17(8):1239-48 (2006)
    542005Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.



    		+-nlAnn Oncol 16(8):1311-9 (2005)
    552005(Neo-)adjuvant treatments in colorectal cancer.



    		+-nlAnn Oncol 16 Suppl 2(-):ii133-40 (2005)
    562004Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool.



    		+-nlAnn Oncol 15 Suppl 4(-):iv283-4 (2004)
    572002Molecular and biochemical markers in colorectal cancer.



    		+-nlAnn Oncol 13 Suppl 4(-):235-45 (2002)
    582001Microsatellite instability: application in hereditary non-polyposis colorectal cancer.



    		+-nlAnn Oncol 12(2):151-60 (2001)
    592007Adjuvant treatment of colorectal cancer.



    		+-nlCA Cancer J Clin 57(3):168-85 (2007)
    601997Surgical treatment of colorectal cancer.



    		+-nlCA Cancer J Clin 47(2):113-28 (1997)
    611997Diagnosing colorectal carcinoma: clinical and molecular approaches.



    		+-nlCA Cancer J Clin 47(2):70-92 (1997)
    622008Systemic therapy for metastatic colorectal cancer: current questions.



    		+-nlCancer 112(9):1879-91 (2008)
    632008Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer.



    		+-nlCancer 112(1):50-4 (2008)
    642007Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer.



    		+-nlCancer 110(5):980-8 (2007)
    652005Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.



    		+-nlCancer 103(12):2435-46 (2005)
    662004Adjuvant postoperative radiotherapy for colon carcinoma.



    		+-nlCancer 101(6):1338-44 (2004)
    672004New systemic frontline treatment for metastatic colorectal carcinoma.



    		+-nlCancer 100(8):1558-77 (2004)
    682010Radiation therapy for rectal cancer: current status and future directions.



    		+-nlCancer Control 17(1):25-34 (2010)
    692010An update on laparoscopic resection for rectal cancer.



    		+-nlCancer Control 17(1):16-24 (2010)
    702010Current progress in targeted therapy for colorectal cancer.



    		+-nlCancer Control 17(1):7-15 (2010)
    712003Methods and results of sphincter-preserving surgery for rectal cancer.



    		+-nlCancer Control 10(3):212-8 (2003)
    722003The role of total mesorectal excision in the management of rectal cancer.



    		+-nlCancer Control 10(3):205-11 (2003)
    732008U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.



    		+-nlClin Cancer Res 14(5):1296-302 (2008)
    742007Radiation therapy in stage II and III rectal cancer.



    		+-nlClin Cancer Res 13(22 Pt 2):6903s-8s (2007)
    752007Multidisciplinary management of patients with advanced rectal cancer.



    		+-nlClin Cancer Res 13(22 Pt 2):6890s-3s (2007)
    762007Management of early rectal T1 and T2 cancers.



    		+-nlClin Cancer Res 13(22 Pt 2):6885s-9s (2007)
    772007Optimal methods for staging rectal cancer.



    		+-nlClin Cancer Res 13(22 Pt 2):6877s-84s (2007)
    782007Newer pathologic assessment techniques for colorectal carcinoma.



    		+-nlClin Cancer Res 13(22 Pt 2):6871s-6s (2007)
    792007Optimal pathologic staging: defining stage II disease.



    		+-nlClin Cancer Res 13(22 Pt 2):6862s-70s (2007)
    802009FDA review of a panitumumab (Vectibix) clinical trial for first-line treatment of metastatic colorectal cancer.



    		+-nlOncologist 14(3):284-90 (2009)
    812007Locally advanced rectal cancer: what is the evidence for induction chemoradiation?



    		+-nlOncologist 12(11):1309-18 (2007)
    822006Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer.



    		+-nlOncologist 11(9):1018-24 (2006)
    832005Critical evaluation of current treatments in metastatic colorectal cancer.



    		+-nlOncologist 10(4):250-61 (2005)
    842006EphB/EphrinB receptors and Wnt signaling in colorectal cancer.



    		+-nlCancer Res 66(1):2-5 (2006)
    852006Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification.



    		+-nlAm J Clin Pathol 125(1):146-53 (2006)
    862005Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept.



    		+-nlAm J Clin Pathol 124(3):380-91 (2005)
    872003Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas.



    		+-nlAm J Clin Pathol 119(6):778-96 (2003) Goldstein NS
    882003Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer.



    		+-nlAm J Clin Pathol 119(6):773-5 (2003)
    892002Beta-catenin--a linchpin in colorectal carcinogenesis?



    		+-nlAm J Pathol 160(2):389-401 (2002)
    901994Colon cancer connections. Cancer syndrome meets molecular biology meets histopathology.



    		+-nlAm J Pathol 145(1):1-6 (1994)
    912008Guidelines for surveillance intervals after polypectomy: coping with the evidence.



    		+-nlAnn Intern Med 148(6):477-9 (2008) Imperiale TF
    922008Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years.



    		+-nlAnn Intern Med 148(6):419-26 (2008)
    932003The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.



    		+-nlAnn Intern Med 138(7):560-70 (2003)
    942001Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.



    		+-nlAnn Intern Med 135(8 Pt 1):577-88 (2001)
    952001Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.



    		+-nlAnn Intern Med 135(8 Pt 1):566-76 (2001)
    961995Prevention of colorectal cancer by endoscopic polypectomy.



    		+-nlAnn Intern Med 123(12):949-50 (1995) Van Dam J
    971993Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology.



    		+-nlAnn Intern Med 119(8):836-43 (1993)
    981963COLON AND RECTAL POLYPS. RELATIONSHIP TO CARCINOMA.



    		+-nlCalif Med 99(-):378-81 (1963)
    992005Chemoradiotherapy for colorectal cancer.



    		+-nlGut 54(8):1194-202 (2005)
    1002005Adherence to BSG adenoma surveillance guidelines will reduce colonoscopic workload.



    		+-nlGut 54(1):173 (2005)
    1012004An update on the genetics of colorectal cancer.



    		+-nlHum Mol Genet 13 Spec No 2(-):R177-85 (2004)
    1022001Deficient DNA mismatch repair: a common etiologic factor for colon cancer.



    		+-nlHum Mol Genet 10(7):735-40 (2001)
    1032004My approach to serrated polyps of the colorectum.



    		+-nlJ Clin Pathol 57(7):682-6 (2004)
    1042008Molecular classification and correlates in colorectal cancer.



    		+-nlJ Mol Diagn 10(1):13-27 (2008)
    1052005Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.



    		+-nlJAMA 293(16):1986-94 (2005)
    1062003Colorectal carcinoma: diagnostic, prognostic, and molecular features.



    		+-nlMod Pathol 16(4):376-88 (2003)
    1072003Gastrointestinal inherited polyposis syndromes.



    		+-nlMod Pathol 16(4):359-65 (2003)
    1081983Familial colonic cancer syndromes.



    		+-nlWest J Med 139(3):351-9 (1983)
    1092009Efficacy of the revised Vienna Classification for diagnosing colorectal epithelial neoplasias.



    		+-nlWorld J Gastroenterol 15(19):2351-6 (2009)
    1102006Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas.



    		+-nlWorld J Gastroenterol 12(37):5932-40 (2006)
    1112003Aberrant crypt foci as microscopic precursors of colorectal cancer.



    		+-nlWorld J Gastroenterol 9(12):2642-9 (2003)
    1122008Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know.



    		+-nlWorld J Gastroenterol 14(21):3281-9 (2008)
    1132007Rectal cancer treatment: improving the picture.



    		+-nlWorld J Gastroenterol 13(44):5805-12 (2007)
    1142006Modern management of rectal cancer: a 2006 update.



    		+-nlWorld J Gastroenterol 12(20):3186-95 (2006)
    1152007The genetics of hereditary colon cancer.



    		+-nlGenes Dev 21(20):2525-38 (2007)
    1162007Flat colorectal neoplasms: definition, importance, and visualization on CT colonography.



    		+-nlAJR Am J Roentgenol 188(4):953-9 (2007)
    1171993Colonic submucosal tumors: a new classification based on radiologic characteristics.



    		+-nlAJR Am J Roentgenol 160(2):315-20 (1993)
    1181991Colorectal cancer: cross-sectional imaging for staging of primary tumor and detection of local recurrence.



    		+-nlAJR Am J Roentgenol 156(5):909-15 (1991)
    1192007Evaluation of submucosal lesions of the large intestine: part 1. Neoplasms.



    		+-nlRadiographics 27(6):1681-92 (2007)
    1202002Differential diagnosis of periampullary carcinomas at MR imaging.



    		+-nlRadiographics 22(6):1335-52 (2002)
    1211995From the archives of the AFIP. Colorectal adenocarcinoma: radiologic-pathologic correlation.



    		+-nlRadiographics 15(1):127-46; quiz 148-9 (1995)
    1222010Restaging of Rectal Cancer with MR Imaging after Concurrent Chemotherapy and Radiation Therapy.



    		+-nlRadiographics 30(2):503-16 (2010)
    1232004Rectal cancer: review with emphasis on MR imaging.



    		+-nlRadiology 232(2):335-46 (2004)
    1242000Diagnosis of colorectal neoplasms at double-contrast barium enema examination.



    		+-nlRadiology 216(1):11-8 (2000)
    1252011Systematic review of pharmacogenetic testing for predicting clinical benefit to anti-EGFR therapy in metastatic colorectal cancer.



    		+-nlAm J Cancer Res 1(5):650-62 (2011)
    1262010Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009.



    		+-nlAnn Oncol 21(8):1579-84 (2010)
    1272010Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up.



    		+-nlAnn Oncol 21 Suppl 5(-):v70-7 (2010)
    1282010Familial colorectal cancer risk: ESMO Clinical Practice Guidelines.



    		+-nlAnn Oncol 21 Suppl 5(-):v78-81 (2010)
    1292010Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 21 Suppl 5(-):v82-6 (2010)
    1302010Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment.



    		+-nlAnn Oncol 21 Suppl 5(-):v93-7 (2010)
    1312010What can the molecular pathologist offer for optimal decision making?



    		+-nlAnn Oncol 21 Suppl 7(-):vii123-9 (2010)
    1322010Chemotherapy: which drug and when?



    		+-nlAnn Oncol 21 Suppl 7(-):vii130-3 (2010)
    1332010How to integrate molecular targeted agents in the continuum of care.



    		+-nlAnn Oncol 21 Suppl 7(-):vii134-9 (2010)
    1342005Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies.



    		+-nlAnn Oncol 16 Suppl 4(-):iv44-49 (2005)
    1352009Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up.



    		+-nlAnn Oncol 20 Suppl 4(-):49-50 (2009)
    1362009Familial colorectal cancer risk: ESMO clinical recommendations.



    		+-nlAnn Oncol 20 Suppl 4(-):51-3 (2009)
    1372009Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 20 Suppl 4(-):54-6 (2009)
    1382009Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 20 Suppl 4(-):61-3 (2009)
    1392010KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.



    		+-nlAnn Surg Oncol 17(4):1168-76 (2010)
    1402008MRI for detection of extramural vascular invasion in rectal cancer.



    		+-nlAJR Am J Roentgenol 191(5):1517-22 (2008)
    1412009Advances in the treatment of metastatic colorectal cancer.



    		+-nlAm J Ther 16(5):412-20 (2009)
    1422010Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.



    		+-nlAm J Gastroenterol 105(8):1851-60 (2010)
    1432010MicroRNAs as biomarkers in colorectal cancer.



    		+-nlAm J Pathol 177(4):1592-9 (2010)
    1442011Lynch syndrome screening implementation: business analysis by a healthcare system.



    		+-nlAm J Manag Care 17(8):e288-300 (2011)
    1452010Colorectal cancer screening: the role of CT colonography.



    		+-nlWorld J Gastroenterol 16(32):3987-94 (2010)
    1462011Multifaceted nature of membrane microdomains in colorectal cancer.



    		+-nlWorld J Gastroenterol 17(6):681-90 (2011)
    1472011Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.



    		+-nlWorld J Gastroenterol 17(6):766-73 (2011)
    1482011Management of stage IV rectal cancer: palliative options.



    		+-nlWorld J Gastroenterol 17(7):835-47 (2011)
    1492011Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior?



    		+-nlWorld J Gastroenterol 17(7):848-54 (2011)
    1502011Sphincter preservation for distal rectal cancer--a goal worth achieving at all costs?



    		+-nlWorld J Gastroenterol 17(7):855-61 (2011)
    1512011Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer?



    		+-nlWorld J Gastroenterol 17(13):1666-73 (2011)
    1522011Patterns of local recurrence in rectal cancer after a multidisciplinary approach.



    		+-nlWorld J Gastroenterol 17(13):1674-84 (2011)
    1532010Surveillance for colitis-associated colon neoplasia.



    		+-nlWorld J Gastroenterol 16(37):4646-51 (2010)
    1542007Diagnostic procedures for submucosal tumors in the gastrointestinal tract.



    		+-nlWorld J Gastroenterol 13(24):3301-10 (2007)
    1552007Therapeutic procedures for submucosal tumors in the gastrointestinal tract.



    		+-nlWorld J Gastroenterol 13(24):3316-22 (2007)
    1562007Serrated neoplasia of the colorectum.



    		+-nlWorld J Gastroenterol 13(28):3792-8 (2007)
    1572007Adjuvant therapies for colorectal cancer.



    		+-nlWorld J Gastroenterol 13(28):3799-805 (2007)
    1582007Metastatic colorectal cancer-past, progress and future.



    		+-nlWorld J Gastroenterol 13(28):3806-15 (2007)
    1592007Combining chemotherapy and targeted therapies in metastatic colorectal cancer.



    		+-nlWorld J Gastroenterol 13(44):5867-76 (2007)
    1602007Colorectal cancer.



    		+-nlMayo Clin Proc 82(1):114-29 (2007)
    1612011Genetics, cytogenetics, and epigenetics of colorectal cancer.



    		+-nlJ Biomed Biotechnol 2011(-):792362 (2011)
    1622011Epithelial tight junctional changes in colorectal cancer tissues.



    		+-nlScientificWorldJournal 11(-):826-41 (2011)
    1632011Molecular imaging using positron emission tomography in colorectal cancer.



    		+-nlDiscov Med 11(60):435-47 (2011)
    1642011The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer.



    		+-nlDiscov Med 11(57):95-105 (2011)
    1652010New strategies for treatment of KRAS mutant metastatic colorectal cancer.



    		+-nlClin Cancer Res 16(11):2921-6 (2010)
    1662010A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.



    		+-nlOncologist 15(7):699-731 (2010)
    1672010Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions.



    		+-nlOncologist 15(2):157-67 (2010)
    1682006Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.



    		+-nlCancer 107(2):221-31 (2006)
    1692005P53 abnormalities and outcomes in colorectal cancer: a systematic review.



    		+-nlBr J Cancer 92(3):434-44 (2005)
    1702009Molecular origins of cancer: Molecular basis of colorectal cancer.



    		+-nlN Engl J Med 361(25):2449-60 (2009)
    1712003Hereditary colorectal cancer.



    		+-nlN Engl J Med 348(10):919-32 (2003)
    1722010The origins of colorectal carcinoma: specific nomenclature for different pathways and precursor lesions.



    		+-nlDtsch Arztebl Int 107(43):760-6 (2010)
    1732006How can we best detect hereditary non-polyposis colorectal cancer?



    		+-nlMed J Aust 184(5):206-7 (2006)
    1742010Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.



    		+-nlHealth Technol Assess 14(Suppl. 2):47-53 (2010)
    1752010Cetuximab for the first-line treatment of metastatic colorectal cancer.



    		+-nlHealth Technol Assess 14 Suppl 1(-):1-8 (2010)
    1762010Kras in metastatic colorectal cancer.



    		+-nlSwiss Med Wkly 140(-):w13112 (2010)
    1772010Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.



    		+-nlChin Med J (Engl) 123(22):3314-8 (2010)
    1782006Rectal cancer.



    		+-nlGastroenterol Clin Biol 30 Spec No 2(-):2S43-2S51 (2006)
    1792006Metastatic colorectal cancer.



    		+-nlGastroenterol Clin Biol 30 Spec No 2(-):2S30-2S42 (2006)
    1802006Colon cancer.



    		+-nlGastroenterol Clin Biol 30 Spec No 2(-):2S24-2S29 (2006)
    1812010Ursodeoxycholic acid and chemoprevention of colorectal cancer.



    		+-nlGastroenterol Clin Biol 34(10):516-22 (2010)
    1822011Fecal occult blood testing while waiting for screening colonoscopy in average-risk individuals: durable option or short-term solution?



    		+-nlCan J Gastroenterol 25(5):247 (2011)
    1832003Elastofibromatous polyp of the sigmoid colon--a case report and review of gastrointestinal elastofibromas.



    		+-nlCan J Gastroenterol 17(4):275-7 (2003)
    1842007Colorectal cancer: imaging surveillance following resection of primary tumour.



    		+-nlCancer Imaging 7 Spec No A(-):S143-9 (2007)
    1852011Strategies in screening for colon carcinoma.



    		+-nlNeth J Med 69(3):112-9 (2011)
    1862005Targeted therapies in the treatment of colorectal cancers.



    		+-nlCancer Control 12(2):105-10 (2005)
    1872005Genomic instability and colorectal cancer.



    		+-nlRev Esp Enferm Dig 97(10):683-7 (2005)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.